Index S&P 500 P/E 33.09 EPS (ttm) 6.50 Insider Own 0.80% Shs Outstand 147.06M Perf Week 16.99%
Market Cap 31.59B Forward P/E 24.69 EPS next Y 8.71 Insider Trans -2.73% Shs Float 145.74M Perf Month 16.63%
Income 958.38M PEG 2.55 EPS next Q 2.08 Inst Own 58.88% Short Float 5.45% Perf Quarter 13.04%
Sales 4.58B P/S 6.89 EPS this Y 19.34% Inst Trans -0.38% Short Ratio 7.26 Perf Half Y 56.43%
Book/sh 31.52 P/B 6.82 EPS next Y 13.29% ROA 14.17% Short Interest 7.95M Perf Year -8.28%
Cash/sh 1.62 P/C 132.77 EPS next 5Y 13.00% ROE 22.39% 52W Range 132.24 - 240.09 Perf YTD 24.99%
Dividend Est. 1.95 (0.91%) P/FCF 28.99 EPS past 5Y 22.66% ROI 16.63% 52W High -10.45% Beta 0.64
Dividend TTM 1.88 (0.87%) Quick Ratio 1.97 Sales past 5Y 12.58% Gross Margin 54.74% 52W Low 62.59% ATR (14) 6.75
Dividend Ex-Date May 08, 2024 Current Ratio 3.04 EPS Y/Y TTM 10.74% Oper. Margin 28.12% RSI (14) 69.63 Volatility 3.82% 2.70%
Employees 10140 Debt/Eq 0.25 Sales Y/Y TTM 14.16% Profit Margin 20.91% Recom 1.79 Target Price 215.12
Option/Short Yes / Yes LT Debt/Eq 0.24 EPS Q/Q 29.19% Payout 28.91% Rel Volume 1.19 Prev Close 213.99
Sales Surprise 1.94% EPS Surprise 10.51% Sales Q/Q 7.17% Earnings Apr 25 AMC Avg Volume 1.09M Price 215.01
SMA20 13.39% SMA50 14.29% SMA200 24.79% Trades
Volume 1,301,001 Change 0.48%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-06-24 Resumed KeyBanc Capital Markets
Overweight
$227
Oct-27-23 Upgrade Morgan Stanley
Equal-Weight → Overweight
$180 → $169
Oct-12-23 Downgrade RBC Capital Mkts
Outperform → Sector Perform
$273 → $202
Oct-09-23 Upgrade JP Morgan
Neutral → Overweight
$210 → $170
Sep-29-23 Downgrade Wolfe Research
Outperform → Peer Perform
Sep-06-23 Upgrade Needham
Hold → Buy
$180
Sep-05-23 Downgrade UBS
Buy → Neutral
$265 → $170
Aug-01-23 Upgrade RBC Capital Mkts
Sector Perform → Outperform
$262 → $284
May-23-23 Initiated UBS
Buy
$290
Apr-14-23 Initiated Mizuho
Buy
$255
Jan-17-23 Upgrade JP Morgan
Neutral → Overweight
$245
Oct-28-22 Downgrade Citigroup
Buy → Neutral
Oct-20-22 Upgrade BofA Securities
Neutral → Buy
$245 → $260
Oct-12-22 Initiated Jefferies
Hold
Sep-08-22 Upgrade Citigroup
Neutral → Buy
Aug-15-22 Downgrade CLSA
Buy → Outperform
Aug-12-22 Downgrade RBC Capital Mkts
Outperform → Sector Perform
$246 → $252
Aug-12-22 Downgrade JP Morgan
Overweight → Neutral
Aug-12-22 Downgrade Citigroup
Buy → Neutral
Jun-06-22 Upgrade RBC Capital Mkts
Sector Perform → Outperform
$233 → $244
Show Previous Ratings
Apr-30-24 01:31PM
09:50AM
Apr-29-24 12:45PM
09:45AM
Apr-27-24 01:06AM
04:08PM
Loading…
Apr-26-24 04:08PM
(Investor's Business Daily) +18.89%
03:57PM
02:12PM
01:48PM
12:17PM
12:08PM
11:45AM
(The Wall Street Journal)
11:35AM
11:26AM
11:01AM
10:33AM
Loading…
10:33AM
10:12AM
10:00AM
(Investor's Business Daily)
08:58AM
08:47AM
08:37AM
08:07AM
07:53AM
06:39AM
06:33AM
(Thomson Reuters StreetEvents)
06:16AM
03:36AM
Apr-25-24 06:30PM
05:43PM
05:25PM
04:49PM
Loading…
04:49PM
04:22PM
(Associated Press Finance)
04:05PM
11:34AM
Apr-22-24 09:16AM
Apr-18-24 04:02PM
(Investor's Business Daily)
10:01AM
Apr-17-24 06:51PM
04:09PM
(Investor's Business Daily)
12:08PM
09:43AM
(The Wall Street Journal)
Apr-04-24 04:05PM
Apr-01-24 12:44PM
Mar-30-24 11:49AM
Mar-15-24 03:05AM
Mar-07-24 09:45AM
07:33AM
Mar-06-24 09:05AM
Feb-24-24 03:10AM
Feb-23-24 11:30AM
Feb-22-24 09:53AM
Feb-20-24 01:35PM
Feb-18-24 01:26PM
Feb-16-24 10:26AM
10:00AM
(The Wall Street Journal)
Feb-13-24 10:23AM
Feb-12-24 04:16PM
Feb-07-24 08:05AM
Feb-05-24 09:45AM
Jan-29-24 04:09PM
10:56AM
12:30AM
Jan-26-24 09:15PM
09:50AM
12:12AM
Jan-25-24 04:05PM
(Investor's Business Daily) +8.48%
12:38PM
(Thomson Reuters StreetEvents)
12:07PM
12:04PM
11:03AM
10:33AM
(Investor's Business Daily)
09:03AM
(Investor's Business Daily)
06:12AM
Jan-24-24 07:00PM
06:07PM
05:25PM
05:22PM
04:43PM
04:27PM
(Associated Press Finance)
04:05PM
Jan-23-24 10:29AM
Jan-19-24 01:05PM
Jan-17-24 12:05PM
09:45AM
Jan-16-24 07:56AM
Jan-12-24 12:58AM
Jan-11-24 05:50PM
Jan-03-24 04:05PM
Dec-27-23 04:05PM
Dec-21-23 11:50PM
Dec-20-23 04:05PM
Dec-14-23 06:17AM
Dec-12-23 09:19AM
Dec-11-23 04:05PM
Dec-07-23 03:34PM
09:50AM
Dec-04-23 05:43AM
Nov-30-23 11:05AM
Nov-12-23 11:45PM
Nov-09-23 04:05PM
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Drexler Karen Director Apr 29 '24 Sale 214.92 425 91,341 8,446 Apr 30 02:17 PM Rider Michael J Global General Counsel Mar 04 '24 Sale 180.00 81 14,580 6,607 Mar 06 08:46 PM Rider Michael J Global General Counsel Mar 01 '24 Sale 173.25 200 34,650 6,688 Mar 04 07:11 PM FARRELL PETER C Director Feb 22 '24 Sale 182.66 10,935 1,997,434 157,404 Feb 23 06:40 PM Sandercock Brett Chief Financial Officer Nov 27 '23 Sale 152.62 3,000 457,860 92,962 Nov 29 07:45 PM Farrell Michael J. Chief Executive Officer Nov 15 '23 Option Exercise 57.76 5,678 327,961 446,664 Nov 16 09:20 PM Farrell Michael J. Chief Executive Officer Nov 15 '23 Sale 152.04 5,678 863,281 440,986 Nov 16 09:20 PM Rider Michael J Global General Counsel Nov 01 '23 Sale 143.42 25 3,585 7,358 Nov 02 09:29 PM Farrell Michael J. Chief Executive Officer Oct 16 '23 Option Exercise 57.76 5,675 327,788 455,035 Oct 17 06:50 PM Farrell Michael J. Chief Executive Officer Oct 16 '23 Sale 140.70 5,675 798,464 449,360 Oct 17 06:50 PM Rider Michael J Global General Counsel Oct 02 '23 Sale 145.92 25 3,648 7,383 Oct 04 10:57 AM Farrell Michael J. Chief Executive Officer Sep 15 '23 Option Exercise 57.76 5,675 327,788 455,035 Sep 19 02:54 PM Farrell Michael J. Chief Executive Officer Sep 15 '23 Sale 146.35 5,675 830,514 449,360 Sep 19 02:54 PM Rider Michael J Global General Counsel Sep 01 '23 Sale 161.15 25 4,029 7,408 Sep 07 03:44 PM Farrell Michael J. Chief Executive Officer Aug 15 '23 Option Exercise 57.76 5,675 327,788 442,605 Aug 17 01:39 PM Farrell Michael J. Chief Executive Officer Aug 15 '23 Sale 183.20 5,675 1,039,647 436,930 Aug 17 01:39 PM Douglas Robert Andrew President and COO Aug 15 '23 Sale 181.01 1,500 271,515 250,526 Aug 16 01:51 PM Rider Michael J Global General Counsel Aug 01 '23 Sale 224.12 25 5,603 5,186 Aug 02 05:30 PM Farrell Michael J. Chief Executive Officer Jul 17 '23 Option Exercise 57.76 5,675 327,788 442,605 Jul 19 12:13 PM Farrell Michael J. Chief Executive Officer Jul 17 '23 Sale 221.27 5,675 1,255,686 436,930 Jul 19 12:13 PM Douglas Robert Andrew President and COO Jul 17 '23 Sale 222.22 1,500 333,330 252,026 Jul 18 05:02 PM Ghoshal Kaushik President, SaaS Business Jul 13 '23 Sale 220.00 500 110,000 11,787 Jul 14 12:26 PM Rider Michael J Global General Counsel Jul 03 '23 Sale 217.21 25 5,430 5,211 Jul 05 02:13 PM Farrell Michael J. Chief Executive Officer Jun 15 '23 Option Exercise 57.76 5,675 327,788 442,605 Jun 16 05:17 PM Farrell Michael J. Chief Executive Officer Jun 15 '23 Sale 217.39 5,675 1,233,716 436,930 Jun 16 05:17 PM Douglas Robert Andrew President and COO Jun 15 '23 Sale 216.27 1,500 324,405 253,526 Jun 20 12:02 PM PENDARVIS DAVID Chief Administrative Officer Jun 05 '23 Sale 219.79 1,500 329,685 89,729 Jun 07 12:20 PM Ghoshal Kaushik President, SaaS Business Jun 02 '23 Sale 220.00 500 110,000 12,287 Jun 06 01:18 PM Farrell Michael J. Chief Executive Officer May 15 '23 Option Exercise 57.76 5,675 327,788 442,605 May 17 02:10 PM Farrell Michael J. Chief Executive Officer May 15 '23 Sale 232.10 5,675 1,317,191 436,930 May 17 02:10 PM Douglas Robert Andrew President and COO May 15 '23 Sale 232.85 1,500 349,275 255,026 May 16 06:07 PM Sandercock Brett Chief Financial Officer May 10 '23 Sale 233.13 12,574 2,931,395 90,942 May 12 07:30 PM Sandercock Brett Chief Financial Officer May 09 '23 Sale 232.05 3,426 795,000 103,516 May 10 05:16 PM FARRELL PETER C Director May 03 '23 Sale 237.17 12,600 2,988,375 166,896 Feb 23 06:40 PM PENDARVIS DAVID Chief Administrative Officer May 03 '23 Sale 237.64 1,500 356,460 91,172 May 04 07:49 PM
Index S&P 500 P/E 24.46 EPS (ttm) 4.89 Insider Own 0.13% Shs Outstand 205.60M Perf Week -1.33%
Market Cap 24.52B Forward P/E 13.76 EPS next Y 8.69 Insider Trans -8.80% Shs Float 204.81M Perf Month -6.94%
Income 1.02B PEG 3.53 EPS next Q 1.87 Inst Own 91.34% Short Float 2.07% Perf Quarter -4.81%
Sales 7.39B P/S 3.32 EPS this Y 6.81% Inst Trans -0.06% Short Ratio 3.07 Perf Half Y 15.62%
Book/sh 60.70 P/B 1.97 EPS next Y 7.74% ROA 4.81% Short Interest 4.25M Perf Year -13.88%
Cash/sh 2.03 P/C 58.97 EPS next 5Y 6.93% ROE 8.36% 52W Range 102.00 - 149.25 Perf YTD -1.76%
Dividend Est. 0.85 (0.71%) P/FCF 25.05 EPS past 5Y - ROI 5.84% 52W High -19.89% Beta 1.04
Dividend TTM 0.96 (0.80%) Quick Ratio 0.78 Sales past 5Y -1.20% Gross Margin 63.02% 52W Low 17.22% ATR (14) 2.30
Dividend Ex-Date Mar 27, 2024 Current Ratio 1.61 EPS Y/Y TTM 344.85% Oper. Margin 18.67% RSI (14) 38.27 Volatility 1.97% 1.86%
Employees 18000 Debt/Eq 0.48 Sales Y/Y TTM 6.55% Profit Margin 13.85% Recom 2.57 Target Price 136.55
Option/Short Yes / Yes LT Debt/Eq 0.40 EPS Q/Q 423.09% Payout 19.66% Rel Volume 1.95 Prev Close 120.28
Sales Surprise 0.61% EPS Surprise 2.15% Sales Q/Q 6.30% Earnings May 02 BMO Avg Volume 1.38M Price 119.56
SMA20 -3.25% SMA50 -4.87% SMA200 -0.78% Trades
Volume 2,702,827 Change -0.60%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-04-24 Downgrade Evercore ISI
Outperform → In-line
$135 → $125
Oct-20-23 Initiated ROTH MKM
Neutral
$120
Aug-28-23 Upgrade BTIG Research
Neutral → Buy
$139
May-03-23 Upgrade BofA Securities
Underperform → Neutral
Apr-11-23 Upgrade Evercore ISI
In-line → Outperform
$135 → $148
Mar-31-23 Upgrade Jefferies
Underperform → Hold
$115 → $130
Mar-29-23 Initiated UBS
Sell
$112
Mar-10-23 Upgrade Piper Sandler
Neutral → Overweight
$135 → $145
Jan-09-23 Upgrade RBC Capital Mkts
Sector Perform → Outperform
$125 → $141
Jan-05-23 Upgrade Raymond James
Mkt Perform → Outperform
$144
Jan-03-23 Downgrade Evercore ISI
Outperform → In-line
$130
Nov-23-22 Upgrade Wells Fargo
Underweight → Equal Weight
Oct-18-22 Initiated Barclays
Underweight
$104
Oct-12-22 Initiated Jefferies
Underperform
$95
May-27-22 Downgrade Needham
Buy → Hold
Apr-13-22 Downgrade Truist
Buy → Hold
$128 → $142
Apr-01-22 Downgrade Citigroup
Buy → Neutral
$125.15 → $135
Mar-02-22 Resumed BofA Securities
Underperform
$120
Mar-02-22 Downgrade Loop Capital
Buy → Hold
$130
Feb-08-22 Reiterated Wells Fargo
Underweight
$124 → $111
Show Previous Ratings
Apr-29-24 09:16AM
Apr-26-24 12:10PM
09:40AM
Apr-25-24 10:01AM
Apr-19-24 10:27AM
09:40AM
Loading…
Apr-10-24 09:40AM
Apr-04-24 07:30AM
Apr-03-24 07:30AM
Mar-27-24 12:23PM
Mar-13-24 04:30PM
Mar-11-24 08:25AM
Mar-08-24 11:29PM
Feb-29-24 09:40AM
Feb-22-24 07:30AM
05:25AM
07:35PM
Loading…
Feb-21-24 07:35PM
07:17AM
07:00AM
Feb-18-24 01:26PM
Feb-15-24 06:09AM
Feb-14-24 06:10AM
(Thomson Reuters StreetEvents)
Feb-12-24 09:40AM
07:30AM
07:00AM
Feb-08-24 02:24PM
10:08AM
09:30AM
08:21AM
07:40AM
06:54AM
06:41AM
Loading…
06:41AM
06:39AM
(Associated Press Finance)
06:30AM
06:09AM
06:09AM
Feb-05-24 09:16AM
Jan-23-24 06:13AM
Jan-22-24 10:42AM
Jan-16-24 07:30AM
Jan-10-24 12:00AM
Jan-05-24 07:30AM
Dec-28-23 10:49AM
Dec-27-23 07:50PM
Dec-19-23 07:30AM
05:00AM
Dec-15-23 07:18AM
(Thomson Reuters StreetEvents)
Dec-14-23 07:00AM
Dec-07-23 11:31AM
Nov-29-23 11:34AM
Nov-24-23 09:50AM
Nov-22-23 09:43PM
Nov-21-23 08:52AM
Nov-16-23 07:30AM
Nov-13-23 02:28PM
Nov-08-23 05:44PM
Nov-07-23 01:37PM
10:49AM
09:30AM
07:40AM
07:20AM
07:16AM
06:55AM
06:45AM
06:38AM
(Associated Press Finance)
06:30AM
Nov-06-23 09:51AM
Nov-05-23 11:17PM
Nov-02-23 11:45AM
09:21AM
Oct-31-23 10:01AM
Oct-30-23 11:31AM
09:00AM
Oct-26-23 11:52AM
Oct-25-23 11:40AM
Oct-20-23 09:37AM
08:45AM
Oct-18-23 12:06PM
Oct-13-23 07:57AM
Oct-12-23 01:52PM
08:14AM
Oct-11-23 11:37AM
Oct-10-23 07:00AM
Oct-05-23 03:28PM
Sep-29-23 12:20PM
08:32AM
Sep-26-23 07:34PM
Sep-14-23 09:40AM
Sep-06-23 04:07PM
(Investor's Business Daily)
11:33AM
Sep-05-23 04:30PM
10:38AM
Sep-03-23 10:30AM
Aug-30-23 09:32AM
Aug-28-23 09:58AM
02:39AM
Aug-27-23 01:54PM
Aug-25-23 05:00PM
Aug-23-23 07:30AM
Aug-22-23 07:38PM
11:38AM
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Winkler Lori SVP and CHRO Apr 01 '24 Option Exercise 0.00 772 0 3,551 Apr 03 04:35 PM Yi Sang Group President, Asia Pacific Mar 07 '24 Option Exercise 91.53 1,705 156,059 19,884 Mar 08 05:03 PM Yi Sang Group President, Asia Pacific Mar 07 '24 Sale 126.86 1,705 216,296 18,179 Mar 08 05:03 PM Upadhyay Suketu Exec. VP, CFO Mar 06 '24 Option Exercise 0.00 4,561 0 22,683 Mar 08 05:05 PM VAN ZUILEN WILFRED Group Pres, EMEA Mar 06 '24 Option Exercise 0.00 2,163 0 7,427 Mar 08 05:05 PM Winkler Lori SVP and CHRO Mar 06 '24 Option Exercise 0.00 1,757 0 3,207 Mar 08 05:05 PM Bezjak Mark President, Americas Mar 06 '24 Option Exercise 0.00 1,622 0 4,753 Mar 08 05:03 PM Ellingson Rachel SVP & Chief Strategy Officer Mar 06 '24 Option Exercise 0.00 1,419 0 7,291 Mar 08 05:03 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Mar 06 '24 Option Exercise 0.00 2,095 0 50,046 Mar 08 05:03 PM Stellato Paul A VP, Controller & CAO Mar 06 '24 Option Exercise 0.00 609 0 1,176 Mar 08 05:04 PM Tornos Ivan President & CEO Mar 06 '24 Option Exercise 0.00 10,270 0 32,395 Mar 08 05:04 PM Yi Sang Group President, Asia Pacific Mar 06 '24 Option Exercise 0.00 2,365 0 18,179 Mar 08 05:03 PM Winkler Lori SVP and CHRO Mar 02 '24 Option Exercise 0.00 186 0 1,496 Mar 05 04:58 PM Yi Sang Group President, Asia Pacific Mar 01 '24 Option Exercise 0.00 2,052 0 15,814 Mar 05 04:59 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Mar 01 '24 Option Exercise 0.00 1,641 0 48,597 Mar 05 05:02 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Feb 25 '24 Option Exercise 0.00 4,580 0 48,725 Feb 27 08:57 PM Tornos Ivan President & CEO Feb 25 '24 Option Exercise 0.00 7,513 0 25,153 Feb 27 08:58 PM Upadhyay Suketu Exec. VP, CFO Feb 25 '24 Option Exercise 0.00 7,043 0 20,213 Feb 27 08:58 PM Bezjak Mark President, Americas Feb 25 '24 Option Exercise 0.00 1,528 0 3,535 Feb 27 08:56 PM Winkler Lori SVP and CHRO Feb 25 '24 Option Exercise 0.00 1,294 0 1,661 Feb 27 08:56 PM Ellingson Rachel SVP & Chief Strategy Officer Feb 25 '24 Option Exercise 0.00 1,762 0 6,460 Feb 27 08:57 PM Yi Sang Group President, Asia Pacific Feb 25 '24 Option Exercise 0.00 5,047 0 13,762 Feb 27 08:55 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Feb 22 '24 Option Exercise 91.53 26,156 2,394,059 70,301 Feb 26 06:02 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Feb 22 '24 Sale 128.62 26,156 3,364,126 44,145 Feb 26 06:02 PM Jafry Syed A. Director Nov 09 '23 Buy 104.75 2,135 223,641 4,060 Nov 13 04:02 PM Kolli Sreelakshmi Director Aug 30 '23 Buy 120.37 1,000 120,370 1,000 Sep 01 04:01 PM HAGEMANN ROBERT Director Aug 28 '23 Buy 116.48 2,000 232,960 4,000 Aug 30 04:03 PM BEGLEY CHRISTOPHER B Director Aug 28 '23 Buy 117.11 1,000 117,114 3,540 Sep 29 04:05 PM MICHELSON MICHAEL W Director Aug 25 '23 Buy 115.50 1,300 150,150 3,385 Aug 29 06:57 PM BERNARD BETSY J Director Aug 25 '23 Buy 114.84 871 100,023 5,271 Aug 29 06:51 PM HIGGINS ARTHUR J Director Aug 23 '23 Buy 115.61 1,000 115,613 3,400 Aug 25 04:31 PM VAN ZUILEN WILFRED Pres, Europe, M. East & Africa Jul 01 '23 Option Exercise 0.00 2,633 0 5,073 Jul 05 04:07 PM Upadhyay Suketu Exec. VP, CFO Jul 01 '23 Option Exercise 0.00 3,768 0 14,660 Jul 05 04:10 PM Stellato Paul A VP, Controller & CAO Jun 01 '23 Option Exercise 0.00 628 0 678 Jun 05 04:03 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
